
Funding for outpatient pharmaceuticals in NZ is among the lowest in the developed world.
Access to innovative medicines in New Zealand remains significantly behind many comparable nations, affecting the health outcomes and quality of life for many New Zealanders, particularly those with … [+3241 chars]









